Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 12.32K |
Day Range | - - - |
52 Wk Range | 2.47 - 4.75 |
Market Cap | $139.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 0.36% |
Days to Cover | 10.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inventiva (NASDAQ:IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Galectin Therapeutics (NASDAQ:GALT), Tevogen Bio Holdings (NASDAQ:TVGN), Agenus (NASDAQ:AGEN), RAPT Therapeutics (NASDAQ:RAPT) and FibroBiologics (NASDAQ:FBLG).
There is no analysis for Inventiva.
Inventiva has a consensus price target of $18.00.
The stock price for Inventiva (NASDAQ: IVA) is $2.66 last updated July 19, 2024 at 9:28 AM EDT.
There are no upcoming dividends for Inventiva.
Inventiva’s H1 earnings are confirmed for Thursday, September 26, 2024.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.